SEARCH

SEARCH BY CITATION

References

  • Abrishamchian AR, Khoury MJ, Calle EE. (1994) The contribution of maternal epilepsy and its treatment to the etiology of oral clefts: a population based case–control study. Genet Epidemiol 11:343351.
  • Adab N. (2004) Common antiepileptic drugs in pregnancy in women with epilepsy adverse features associated with higher doses of sodium valproate. Seizure 11:512518.
  • Adab N, Jacoby A, Smith D, Chadwick D. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:1521.
  • Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:15751583.
  • Annegers JF, Hauser I. (1982) The frequency of malformations in relatives of patients with epilepsy. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 267273.
  • Annegers JF, Elveback LR, Hauser WA, Kurland LT. (1974) Do anticonvulsants have a teratogenic effect? Arch Neurol 31:364373.
  • Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland LI. (1978) Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 7:241247.
  • Anonymous (2006). Lamotrigine possibly linked to cleft palate/lip, warns FDA. Reactions Weekly October 7, 2006. 1122: 2.
  • Arpino C, Brescianini S, Robert E, Craig J, Lindhout D, Perucca E. (2000) Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41:14361443.
  • Artama M, Isojärvi JI, Raitanen J, Auvinen A. (2004) Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am J Epidemiol 159:10571063.
  • Artama M, Auvinen A, Raudaskoski T, Isojärvi I, Isojärvi J. (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64:18741878.
  • Bardy AH. (1987) Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study. Acta Neurol Scand 75:356360.
  • Barrett C, Richens A. (2003) Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res 52:147187.
  • Battino D. (2000) Anticonvulsants. In DukesG, AronsonJK (Eds) Meyler’s side effects of drugs. 14th ed. Elsevier Science B.V., Amsterdam, pp. 164197.
  • Battino D. (2001) Assessment of teratogenic risk. Epilepsy Res 45:171173.
  • Battino D, Kaneko S, Andermann E. (1999) Intrauterine growth in the offspring of epileptic women: a prospective multicenter study. Epilepsy Res 36:5360.
  • Beck-Mannagetta G, Janz D. (1982) Data on psychomotor and mental development in children of epileptic mothers: a retrospective study. In: JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 443445.
  • Beck-Mannagetta G, Drees B, Janz D (1982) Malformations and minor anomalies in the offspring of epileptic parents: a retrospective study. In: JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 317323.
  • Bertollini R, Mastroiacovo P, Segni G. (1985) Maternal epilepsy and birth defects: a case–control study in the Italian Multicentric Registry of Birth Defects (IPIMC). Eur J Epidemiol 1:6772.
  • Bertollini R, Källen B, Mastroiacovo P, Robert E. (1987) Anticonvulsant drugs in monotherapy. Effect on the fetus. Eur J Epidemiol 3:164171.
  • Blumenfeld Z, Siegler E, Bronshstein M. (1993) The early diagnosis of neural tube defects. Prenat Diagn 13:863871.
  • Camp BW, Broman SH, Nichols PL, Leff M. (1998) Maternal and neonatal risk factors for mental retardation: defining the ‘at-risk’ child. Early Hum Dev 50:159173.
  • Canger R. (1982) Modifications of seizure frequency in pregnant patients with epilepsy: a prospective study. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 3338.
  • Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, Mamoli D, Palmieri C, Molteni F, Granata T, Hassibi P, Zamperini P, Pardi G, Avanzini G. (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:12311236.
  • Chmait R, Pretorius D, Jones M, Hull A, James G, Nelson T, Moore T. (2002) Prenatal evaluation of facial clefts with two-dimensional and adjunctive three-dimensional ultrasonography: a prospective trial. Am J Obstet Gynecol 187:946949.
  • Choulika S, Grabowski E, Holmes LB. (2004) Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am J Obstet Gynecol 190:882883.
  • Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists: ACOG educational bulletin. (1997) Seizure disorders in pregnancy. Int J Gynaecol Obstet 56:279286.
  • Comstock CH. (2000) What to expect from routine midtrimester screening for congenital heart disease. Semin Perinatol 24:331342.
  • Crawford P. (2005) Best practice guidelines for the management of women with epilepsy. Epilepsia 46(Suppl. 9):117124.
  • D’Souza SW, Robertson IG, Donnai D, Mawer G. (1991) Fetal phenytoin exposure, hypoplastic nails, and jitteriness. Arch Dis Child 66:320324.
  • Dansky L. (1989) Outcome of pregnancy in epileptic women. PhD Thesis. Mc Gill University.
  • Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. (2002) Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39:251259.
  • Delgado-Escueta AV, Janz D. (1992) Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 42:149160.
  • Dessens AB, Boer K, Koppe JG, Vandepoll NE, Cohenkettenis PT. (1994) Studies on long-lasting consequences of prenatal exposure to anticonvulsant drugs. Acta Paediatr Suppl 404:5464.
  • Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. (2001) Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 57:321324.
  • Dolk H, McElhatton P. (2002) Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications. J Med Genet 39:243244.
  • Dravet C, Julian C, Legras C, Magaudda A, Guerrini R, Genton P, Soulayrol S, Giraud N, Mesdjian E, Trentin G, Roger J, Ayme S. (1982) Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 42(4 Suppl. 5):7582.
  • Dronamraju KR. (1970) Epilepsy and cleft lip and palate. Lancet 2:876877.
  • Duncan S. (2003) The effects of valproic acid on the outcome of pregnancy: a prospective study. Epilepsia 44(Suppl. 8):59.
  • Elshove J, Van Eck JH. (1971) Congenital abnormalities, cleft lip and cleft palate in particular, in children of epileptic mothers. Ned Tijdschr Geneeskd 115:13711375.
  • Erickson JD, Oakley GP. (1974) Seizure disorder in mothers of children with orofacial clefts: a case–control study. J Pediatr 184:244246.
  • Eriksson K, Viinikainen K, Monkkonen A, Aikia M, Nieminen P, Heinonen S. (2005) Children exposed to valproate in utero population-based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65:189200.
  • Eskazan E, Aslan S. (1992) Antiepileptic therapy and teratogenicity in Turkey. Int J Clin Pharmacol Ther Toxicol 30:261264.
  • Fairgrieve SD, Jackson M, Jonas P, Walshaw D, White K, Montgomery TL, Burn J, Lynch SA. (2000) Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ 321:674675.
  • Fedrick J. (1973) Epilepsy and pregnancy: a report from the Oxford Record Linkage Study. BMJ 2:442448.
  • Fonager K, Larsen H, Pedersen L, Sørensen HT. (2000) Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol Scand 101:289294.
  • Fried S, Kozer E, Nulman I, Einarson TR, Koren G. (2004) Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf 27:197202.
  • Friis ML. (1979) Epilepsy among parents of children with facial clefts. Epilepsia 20:6976.
  • Friis ML, Hauge M. (1985) Congenital heart defects in live-born children of epileptic parents. Arch Neurol 42:374376.
  • Fujioka K (1984) A study of the psychomotor development of the offspring of epileptic mothers. In SatoT, ShinagawaS (Eds) Antiepileptic drugs and pregnancy. Excerpta Medica, Amsterdam, Princeton, Geneva, Tokyo, pp. 196206.
  • Gaily E, Granstrom ML. (1989) A transient retardation of early postnatal growth in drug- exposed children of epileptic mothers. Epilepsy Res 4:147155.
  • Gaily E, Kantola-Sorsa E, Granstrom ML. (1990) Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 32:403414.
  • Gaily E, Kantola-Sorsa E, Granstrom ML. (1998) Intelligence of children of epileptic mothers. J Pediatr 113:677684.
  • Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, Nylund T, Bardy A, Kaaja E, Granström ML. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:2832.
  • Galimberti CA, Mazzucchelli I, Arbasino C, Canevini MP, Fattore C, Perucca E. (2006) Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy. Epilepsia 47:15691572.
  • Gjerde IO, Strandjord RE, Ulstein M. (1988) The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand 78:198205.
  • Gramstrom ML. (1982) Development of the children of epileptic mothers: preliminary results from the prospective Helsinki study. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 403408.
  • Greenberg G, Inman WH, Weatherall JA, Adelstein AM, Haskey JC. (1977) Maternal drug histories and congenital abnormalities. BMJ 2:853856.
  • Hanson JW, Myrianthopoulos NC, Harvey MA, Smith DW. (1976) Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89:662668.
  • Hattig H, Helge H, Steinhausen HC. (1987) Infants of epileptic mothers: development scores at 18 months. In WolfP, DamM, JanzD (Eds) Advances in Epileptology. Raven Press, New York, pp. 403408.
  • Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153:961968.
  • Hiilesmaa VK, Teramo K, Granstrom ML, Bardy AH. (1981) Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet 2:165167.
  • Hill BC. (1982) Relation between antiepileptic drug exposure of the infant and developmental potential. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 409417.
  • Hirano T, Fujioka K, Okada M, Iwasa M, Kaneko S. (2004) Physical and psychomotor development in the offspring born to mothers with epilepsy. Epilepsia 45(Suppl. 8):5357.
  • Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med 344:11321138.
  • Holmes LB, Wyszynski DF, Lieberman E. (2004) The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61:673678.
  • Holmes LB, Wyszynski DF, Baldwin EJ, Habecker E, Glassman LH, Smith CR. (2006) Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy. Birth Defects Res A Clin Mol Teratol 78:318.
  • Hvas CL, Henriksen TB, Østergaard JR, Dam M. (2000) Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. Br J Obstet Gynaecol 107:896902.
  • Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. (1999) Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 31:8185.
  • Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329:13831388.
  • Jager-Roman E. (1982) Somatic parameters, diseases and psychomotor development in the offspring of epileptic parents. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 425432.
  • Jager-Roman E, Deichi A, Jakob S. (1986) Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 108:9971004.
  • Jick SS, Terris BZ. (1997) Anticonvulsants and congenital malformations. Pharmacotherapy 17:561564.
  • Jones KL, Lacro RV, Johnson KA, Adams J. (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:16611666.
  • Kaaja E, Kaaja R, Matila R, Hiilesmaa V. (2002) Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58:549553.
  • Kaaja E, Kaaja R, Hiilesmaa V. (2003) Major malformations in offspring of women with epilepsy. Neurology 60:575579.
  • Kallen B. (1986) A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol Scand 73:253259.
  • Kallen B, Robert E, Mastroiacovo P, Martinez-Frias M, Castilla E, Cocchi G. (1989) Anticonvulsant drugs and malformations is there a drug specificity? Eur J Epidemiol 5:3136.
  • Kaneko S, Otani K, Fukushima Y, Ogawa Y, Nomura Y, Ono T, Nakane Y, Teranishi T, Goto M. (1988) Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 29:459467.
  • Kaneko S, Otani K, Fukushima Y. (1992) Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. Neurology 42:6874.
  • Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, Nakane Y, Ogawa Y, Avanzini G, Fumarola C, Granata T, Molteni F, Pardi G, Minotti L, Canger R, Dansky L, Oguni M, Lopes-Cendas I, Sherwin A, Andermann F, Seni MH, Okada M, Teranishi T. (1999) Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145158.
  • Kelly TE, Edwards P, Rein M, Miller JQ, Dreifuss FE. (1984a) Teratogenicity of anticonvulsant drugs. IV: the association of clefting and epilepsy. Am J Med Genet 19:451458.
  • Kelly TE, Edwards P, Rein M, Miller JQ, Dreifuss FE. (1984b) Teratogenicity of anticonvulsant drugs. II: a prospective study. Am J Med Genet 19:435443.
  • Kilpatrick CJ, Hopper JL. (1993) The effect of pregnancy on the epilepsies: a study of 37 pregnancies. Aust N Z J Med 23:370373.
  • Knight AH, Rhind EG. (1975) Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 16:99110.
  • Koch S, Hartmann A, Juger-Roman E, Rating D, Helge H. (1982) Major malformation in children of epileptic mothers–due to epilepsy or its therapy?. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 313315.
  • Koch S. (1983) [Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development]. Dtsch Med Wochenschr 108:250257.
  • Koch S, Losche G, Jager-Roman E, Jakob S, Rating D, Deichl A, Helge H. (1992) Major and minor birth malformations and antiepileptic drugs. Neurology 42(4 Suppl. 5):8388.
  • Koch S, Titze K, Zimmermann RB, Schröder M, Lehmkull U, Rauh H. (1999) Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 40:12371243.
  • Krishnamurthy K. (2002) Pregnant women with epilepsy taking oLoEr anticonvulsants must have their drug levels checked frequently to avoid seizures. Epilepsia 43(Suppl. 7):232233. [Abstract]
  • Lander CM, Eadie MJ. (1990) Antiepileptic drug intake during pregnancy and malformed offspring. Epilepsy Res 7:7782.
  • Lander CM, Eadie MJ. (1991) Plasma antiepileptic drug concentrations during pregnancy. Epilepsia 32:257266.
  • Leavitt AM, Yerby MS, Robinson N, Sells CJ, Erickson DM. (1992) Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology 42(4 Suppl. 5):141143.
  • Leonard G, Andermann E, Ptito P, Schopflocher C. (1997) Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring. Epilepsia 38(Suppl. 3):170.
  • Leonard H, De Klerk N, Bourke J, Bower C. (2006) Maternal health in pregnancy and intellectual disability in the offspring: a population-based study. Ann Epidemiol 16:448454.
  • Lindhout D. (1982) Hazards of fetal exposure to drugs combination. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 275281.
  • Lindhout D, Schmidt D. (1986) In-utero exposure to valproate and neural tube defects. Lancet 1:13921393.
  • Lindhout D, Meinardi H. (1984) Spina bifida and in-utero exposure to valproate. Lancet 2:396.
  • Lindhout D, Hoppener RJ, Meinardi H. (1984) Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 25:7783.
  • Lindhout D, Meinardi H, Meijer JW, Nau H. (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 142(4 Suppl. 5):94110.
  • Losche G, Steinhausen HC, Koch S, Helge H. (1994) The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 83:961966.
  • Majewski F, Steger M, Richter B, Gill J, Rabe F. (1981) The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy 2:3745.
  • Mawer G, Clayton-Smith J, Coyle H, Kini U. (2002) Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 11:512518.
  • Meadow SR. (1970) Congenital abnormalities and anticonvulsant drugs. Proc R Soc Med 63:4849.
  • Meyer JG. (1973) The teratological effects of anticonvulsants and the effects on pregnancy and birth. Eur Neurol 10:179190.
  • Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. (2004) Spina bifida. Lancet 364:18851895.
  • Morrow JI, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. (2006) Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193198.
  • Nakane Y, Okuma T, Takahashi R, Sato Y, Wada T, Sato T, Fukushima Y, Kumashiro H, Ono T, Takahashi T, Aoki Y, Kazamatsuri H, Inami M, Komai S, Seino M, Miyakoshi M, Tanimura T, Hazama H, Kawahara R, Otsuki S, Hosokawa K, Inanaga K, Nakazawa Y, Yamamoto K. (1980) Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 21:663680.
  • Nakane Y. (1982) Factors influencing the risk of malformations among infants born to epileptic mothers. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 259–265.
  • National Institute for Clinical Excellence. (2004) Clinical Guideline 20. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care, pp. 3135. Available at http://www.nice.org.uk/Guidance/CG20/NiceGuidance/pdf/English [Accessed November 26, 2008].
  • Nelson KB, Ellenberg JH. (1982) Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children. Neurology 32:12471754.
  • Nomura Y. (1984) The physical and mental development of infants born to mothers treated with antiepileptic drugs. In SatoT, ShinagawaS (Eds) Antiepileptic drugs and pregnancy. Excerpta Medica, Amsterdam, pp. 187195.
  • O’Brien MD, Gilmour-White SK. (2005) Management of epilepsy in women. Postgrad Med 81:278285.
  • O’Brien MD, Guillebaud J. (2006) Contraception for women with epilepsy. Epilepsia 47:14191422.
  • Oguni M, Dansky L, Andermann E, Sherwin A, Andermann F. (1992) Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy. Brain Dev 14:371380.
  • Ohtsuka Y, Silver K, Andermann E, Lopes-Cends I, Tsuda T. (1999) Effect of antiepileptic drugs on psychomotor development of offspring of epileptic mothers. Epilepsia 40(Suppl. 2):296.
  • Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G. (1998) Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39:887892.
  • Omtzigt JG, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H, Stewart PA, Gaillard HL, Sachs ES, Wladimiroff JW et al. (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42(4 Suppl. 5):119125.
  • Ornoy A, Cohen E. (1996) Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 75:517520.
  • Otani K. (1985) Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn 39:3341.
  • Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. (2004) The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 62:292295.
  • Perucca E, Crema A. (1982) Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet 7:336352.
  • Perucca E. (1987) Drug metabolism in pregnancy, infancy and childhood. Pharmacol Ther 34:129143.
  • Perucca E. (2006) Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 61:246255.
  • Petitti DB. (2003) Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med 349:14431450.
  • Quality Standards Subcommittee of the American Academy of Neurology. (1998) Practice parameter: management issues for women with epilepsy (summary statement). Epilepsia 39:12261231.
    Direct Link:
  • Rasgon N. (2004) The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol 24:322334.
  • Rating D. (1987) Major malformations and minor anomalies in the offspring of epileptic parents: the role of antiepileptic drugs. In NauH, ScottWJ Jr (Eds) Pharmacokinetics in teratogenesis. CRC Press, Boca Raton, FL, pp. 205224.
  • Royal College of Obstetricians and Gynecologists. (2008) Screening for structural anomalies. In WelshA (Ed) Antenatal care: routine care for the healthy pregnant woman. RCOG Press, London, pp. 134153.
  • Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274:15181525.
  • Remillard G. (1982) Seizure frequency during pregnancy and puerperium. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, Pregnancy, and the Child. Raven Press, New York, pp. 1525.
  • Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. (2004) Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 190:371379.
  • Robert E, Guibaud P. (1982) Maternal valproic acid and congenital neural tube defects. Lancet 2:937.
  • Robinson JN, McElrath TF, Benson CB, Doubilet PM, Westgate MN, Holmes L, Lieberman ES, Norwitz ER. (2001) Prenatal ultrasonography and the diagnosis of fetal cleft lip. J Ultrasound Med 20:11651170.
  • Robinson JN, Simpson LL, Abuhamad AZ. (2003) Screening for fetal heart disease with ultrasound. Clin Obstet Gynecol 46:890896.
  • Rodriguez-Pinilla E, Arroyo I, Fondevilla J. (2000) Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case–control study. Am J Med Genet 90:376381.
  • Rosa FW. (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324:674677.
  • Rovet J, Cole S, Nulman I. (1995) Effects of maternal epilepsy on children’s neurodevelopment. Child Neuropsychol 1:150157.
  • Sabers A, Rogvi-Hansen B, Dam M, Fischer-Rasmussen W, Gram L, Hansen M, Moller A, Winkel H. (1998) Pregnancy and epilepsy: a retrospective study of 151 pregnancies. Acta Neurol Scand 97:164170.
  • Sabers A, Dam M, Rogvi-Hansen B, Boas J, Sidenius P, Laue FM. (2004) Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 109:913.
  • Samren EB, Van Duijn C, Koch S. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38:981990.
  • Samrén EB, Van Duijn CM, Christiaens GCML, Hofman A, Lindhout D. (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739746.
  • Schmidt D. (1982a) The effect of pregnancy on the course of epilepsy: a prospective study. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, Pregnancy, and the Child. Raven Press, New York, pp. 3949.
  • Schmidt D. (1982b) The effect of pregnancy on the natural history of epilepsy. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, Pregnancy, and the Child. Raven Press, New York, pp. 314.
  • Schmidt D, Canger R, Avanzini G, Battino D, Cusi C, Beck-Mannagetta G, Koch S, Rating D, Janz D. (1983) Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 146:751755.
  • Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, Gladstone R, Ashby P, Weksberg R, Einarson T et al. (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767770.
  • Scottish Intercollegiate Guidelines Network. (2003) Guideline No. 70. Diagnosis and management of epilepsy in adults. Available at: http://www.sign.ac.uk/pdf/sign70.pdf [Accessed November 26, 2008].
  • Shakir RA, Abdulwahab B. (1991) Congenital malformations before and after the onset of maternal epilepsy. Acta Neurol Scand 84:153156.
  • Shapiro S, Hartz SC, Siskind V, Mitchell AA, Slone D, Rosenberg L, Monson RR, Heinonen OP. (1976) Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1:272275.
  • Società Italiana di Ecografia Ostetrico-Ginecologica. (2006) Linee Guida SIEOG 2006. Available at: http://www.sieog.it/Documenti/LineeGuida/2006/LineeGuida2006.pdf [Accessed November 26, 2008].
  • Specchio LM. (1989) Frequenza delle crisi epilettiche durante la gravidanza in un’osservazione prospettica. Boll Lega It Epil 66/67:299301.
  • Speidel BD, Meadow SR. (1972) Maternal epilepsy and abnormalities of fetus and the newborn. Lancet 1:839843.
  • Starreveld-Zimmerman AA, Van Der Kolk WJ, Meinardi H, Elshove J. (1973) Are anticonvulsants teratogenic? Lancet 2:4849.
  • Steegers-Theunissen RP, Renier WO, Borm GF, Thomas CM, Merkus HM, Op de Coul DA, De Jong PA, Van Geijn HP, Wouters M, Eskes TK. (1994) Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study. Epilepsy Res 18:261269.
  • Steinhausen HC, Lösche G, Koch S, Helge H. (1994) The psychological development of children of epileptic parents. I. Study design and comparative findings. Acta Paediatr 83:955960.
  • Stoll C, Clementi M. (2003) Prenatal diagnosis of dysmorphic syndromes by routine fetal ultrasound examination across Europe. Ultrasound Obstet Gynecol 21:543551.
  • Tanganelli P, Regesta G. (1992) Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. Neurology 42(4 Suppl. 5):8993.
  • Taruscio D, Agazio E, Salerno P. (2005) Prevenzione primaria di difetti congeniti mediante una vitamina: l’acido folico. Notiziario Istituto Superiore Sanità 18:1117.
  • Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. (1979) Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 7:36.
  • Teramo K, Hiilesmaa V. (1982) Pregnancy and fetal complications in epileptic pregnancies. In JanzD, DamM, BossiL, HelgeH, RichensA, SchmidtD (Eds) Epilepsy, pregnancy, and the child. Raven Press, New York, pp. 5359.
  • Tettenborn B, Genton P, Polson D. (2002) Epilepsy and women’s issues: an update. Epileptic Disord 4(Suppl. 2):S23S31.
  • The EURAP Study Group. (2006) Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 66:354360.
  • Thomas SV, Devi CC, Radhakrishnan K, Joshua CS. (2001) Seizure pattern during pregnancy and puerperium among women with epilepsy. Epilepsia 41(Suppl. 7):98. [Abstract]
  • Thorneycroft I, Klein P, Simon J. (2006) The impact of antiepileptic drug therapy on steroidal contraceptive efficacy. Epilepsy Behav 9:3139.
  • Tomson T, Lindbom U, Ekqvist B, Sundqvist A. (1994) Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 35:122130.
  • Tomson T, Perucca E, Battino D. (2004) Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 45:11711775.
  • Tomson T. (2005) Gender aspects of pharmacokinetics of new and old AEDs: pregnancy and breast-feeding. Ther Drug Monit 27:718721.
  • Tomson T, Luef G, Sabers A, Pittschieler S, Ohman I. (2006) Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives. Neurology 67:12791281.
  • Tomson T, Battino D. (2007) Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and puerperium. Clin Pharmacokinet 46:209219.
  • Vajda FJ, O’Brien TJ, Hitchcock RN, Graham J, Lander C. (2003) The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci 10:543549.
  • Van den Hof MC, Nicolaides KH, Campbell J, Campbell S. (1990) Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol 162:322327.
  • Van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. (1991) Antiepileptic medication in pregnancy: late effects on the children’s central nervous system development. Am J Obstet Gynecol 164:121128.
  • Vanoverloop D, Schnell RR, Harvey EA, Holmes LB. (1992) The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 14:32935.
  • Vidovic MI, Della Marina BM. (1994) Trimestral changes of seizure frequency in pregnant epileptic women. Acta Med Croatica 48:8587.
  • Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA, Liverpool and Manchester Neurodevelopment Study Group. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64:949954.
  • Waters CH, Bellai I, Gott PS, Shen P, De Giorgio CM. (1994) Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 51:250253.
  • Weber M, Schweitzer M, Mur JM, Andre JM, Tridon P, Vert P. (1977) Epilepsy, anticonvulsants and pregnancy. Arch Fr Pediatr 34:374383.
  • Wide K, Winbladh B, Tomson T, Sars-Zimmer K, Berggren E. (2000a) Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study. Dev Med Child Neurol 42:8792.
  • Wide K, Winbladh B, Tomson T. (2000b) Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years. Epilepsia 41:854861.
  • Wide K, Henning E, Tomson T, Winbladh B. (2002) Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91:409414.
  • Wide K, Winbladh B, Kallen B. (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93:174176.
  • Wilhelm J, Morris D, Hotham N. (1990) Epilepsy and pregnancy – a review of 98 pregnancies. Aust N Z J Obstet Gynaecol 30:290295.
  • Wooltorton E. (2005) Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss. CMAJ 172:746.
  • Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64:961965.
  • Yerby MS, Friel PN, McCormick K, Koerner M, Van M, Leavitt AM, Sells CJ, Yerby JA. (1990) Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res 5:223228.
  • Yerby MS, Friel PN, McCormick K. (1992a) Antiepileptic drug disposition during pregnancy. Neurology 42:1216.
  • Yerby MS, Laevitt A, Erickson DM, McCormick KB, Loewenson RB, Sells CJ, Benedetti TJ. (1992b) Antiepileptics and the development of congenital anomalies. Neurology 42(4 Suppl. 5):132140.
  • Zahn C. (1998) Neurologic care of pregnant women with epilepsy. Epilepsia 39(Suppl. 8):2631.